Investing.com -- Cigna Group is contending with elevated industry-wide medical costs that are expected to weigh on its Healthcare segment in 2025, according to CFRA, which downgraded the stock to Hold in a note Tuesday. “CI faces industry-wide cost pressures from stop-loss plans and higher medical utilization including deferred pandemic care,” CFRA analysts wrote, noting this dynamic will likely affect earnings growth next year despite recent gains in the company’s pharmacy business. Cigna’s medical cost ratio (MCR), which tracks the share of premiums spent on claims, rose to 83.2% in 2024, up from 81.3% in 2023. The company expects that ratio to remain elevated in 2025, guiding for an average of 83.2% to 84.2%. “This reflects higher costs from stop-loss plans,” CFRA said. The firm projects 2025 earnings per share of $29.67, up 9% from 2024, and sees EPS growing 11% in 2026 to $35.00. Cigna’s long-term EPS growth target has been raised to a 12% midpoint, up from 11.5%, supported by a $6 billion increase to its share repurchase authorization. Despite the headwinds in its Healthcare unit, CFRA highlighted positives in Cigna’s Evernorth segment, which “benefits from healthy pharmaceutical volumes and services.” They said that in 2024, Evernorth’s growth was fueled by a 20-million-member pharmacy contract win from Centene (NYSE:CNC) and strong specialty drug volumes. CFRA also supported Cigna’s $3.7 billion divestiture of its Medicare businesses to Health Care Service Corporation, calling it “a strategically sound move we expect to be margin accretive.” CFRA’s 12-month price target of $392 on the stock reflects a 13.2x multiple of 2025 EPS, slightly above Cigna’s five-year average, justified by “balance sheet improvement, pharmaceutical business momentum in Evernorth, and strength in Commercial health insurance.” Related articles CFRA: Cigna Group ’faces industry-wide cost pressures’ Paul Tudor Jones predicts new stock market lows despite potential tariff reduction HF Foods Group unveils e-commerce platform, rebrands with new logo View Comments
CFRA: Cigna Group ’faces industry-wide cost pressures’
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...